We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Renal Cell Carcinoma

Journal Scan / Research · October 06, 2022

Association of Cachexia Index Score With Survival Outcomes in Patients With mRCC Treated With Immunotherapy

Urologic Oncology: Seminars and Original Investigations

 

Additional Info

Disclosure statements are available on the authors' profiles:

Urologic Oncology: Seminars and Original Investigations
Cachexia index in predicting outcomes among patients receiving immune checkpoint inhibitor treatment for metastatic renal cell carcinoma
Urol. Oncol 2022 Sep 19;[EPub Ahead of Print], V Aslan, ACK Kılıç, O Sütcüoğlu, E Eraslan, A Bayrak, B Öksüzoğlu, G Tahtacı, N Özdemir, A Üner, N Günel, A Özet, O Yazıcı

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading